The novel prognostic risk factor STC2 can regulate the occurrence and progression of osteosarcoma via the glycolytic pathway
Bo Yu, Feifei Zhang, Lang Liu, Yiping Liang, Xiaofeng Tang, Yuanxiang Peng, Feng Cai, Duo Zeng, Xuhui Yuan, Jiayu Li, Yuhong Guo, Bin Lv, Min Wang, Qi Liao, Xiaobin Lv
Topics & Concepts
OsteosarcomaGlycolysisCancer researchWarburg effectCancerTumor progressionMedicineInternal medicineOxidative phosphorylationOncologyBiologyMetabolismBiochemistryCancer, Hypoxia, and MetabolismRNA modifications and cancerSarcoma Diagnosis and Treatment